This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names [Yahoo! Finance]
Definium Therapeutics, Inc. - Common Shares (DFTX)
Company Research
Source: Yahoo! Finance
On February 17, 2026, Superstring Capital Management disclosed a new position in Definium Therapeutics (NASDAQ:DFTX) , acquiring 425,202 shares in the fourth quarter. What happened According to a SEC filing dated February 17, 2026, Superstring Capital Management reported acquiring 425,202 shares of Definium Therapeutics. The quarter-end value of this new stake was $5.69 million, reflecting the new share purchases. What else to know The DFTX position is new and accounts for 3.05% of Superstring Capital Management LP's reportable U.S. equity assets as of December 31, 2025. Top five holdings after the filing: NASDAQ: CDTX: $18.80 million (10.1% of AUM) NASDAQ: TERN: $17.93 million (9.6% of AUM) NASDAQ: URGN: $16.82 million (9.0% of AUM) NASDAQ: COGT: $13.01 million (7.0% of AUM) NASDAQ: DVAX: $8.08 million (4.3% of AUM) As of Wednesday, Definium Therapeutics shares were priced at $17.43, up 170% over the past year and well outperforming the S&P 500's roughly 19% ga
Show less
Read more
Impact Snapshot
Event Time:
DFTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DFTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DFTX alerts
High impacting Definium Therapeutics, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
DFTX
News
- Definium Therapeutics Teases Phase III DT120 Data for Anxiety, Depression at Leerink Conference [Yahoo! Finance]Yahoo! Finance
- Definium Therapeutics Announces New Employee Inducement GrantsBusiness Wire
- Definium Therapeutics (DFTX) had its price target raised by HC Wainwright from $55.00 to $70.00. They now have a "buy" rating on the stock.MarketBeat
- Definium Therapeutics Weighs Breakthrough Status Against Valuation And Trial Risks [Yahoo! Finance]Yahoo! Finance
- Definium Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
DFTX
Earnings
- 2/26/26 - Miss
DFTX
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- DFTX's page on the SEC website